Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.
Saved in:
| Title: | Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial. |
|---|---|
| Authors: | Nassiri F; Division of Neurosurgery, University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Patil V; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Yefet LS; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Singh O; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Liu J; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Dang RMA; Department of Human Genetics, University of California Los Angeles, Los Angeles, CA, USA., Yamaguchi TN; Department of Human Genetics, University of California Los Angeles, Los Angeles, CA, USA., Daras M; Division of Neuro-oncology, University of California San Francisco, San Francisco, CA, USA., Cloughesy TF; UCLA Neuro-Oncology Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Colman H; Huntsman Cancer Institute and Department of Neurosurgery, University of Utah, Salt Lake City, UT, USA., Kumthekar PU; Department of Neurology, Division of Neuro-Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Chen CC; Department of Neurosurgery, University of Minnesota, Minneapolis, MI, USA., Aiken R; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA., Groves MD; Department of Neurology, Texas Oncology, Austin, TX, USA., Ong SS; Division of Neuro-Oncology, Department of Neurology, the Ohio State University Wexner Medical Center, Columbus, Ohio, USA., Ramakrishna R; Department of Neurological Surgery, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA., Vogelbaum MA; Department of Neuro-Oncology, Neuro-Oncology Program, Moffitt Cancer Center, Tampa, FL, USA., Khagi S; Division of Medical Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Kaley T; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Melear JM; Department of Internal Medicine, Baylor University Medical Center, Dallas, TX, USA., Peereboom DM; The Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH, USA., Rodriguez A; Department of Neurosurgery, University of Arkansas for Medical Sciences, Little Rock, AK, USA., Yankelevich M; Department of Pediatrics, University of Michigan, Ann Arbor Beaumont Children's Hospital, Royal Oak, MI, USA., Nair SG; Lehigh Valley Topper Cancer Institute, Allentown, PA, USA., Puduvalli VK; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Aldape K; Laboratory of Pathology, National Cancer Institute, Bethesda, MD, USA., Gao A; Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto, Ontario, Canada., López-Janeiro Á; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdISNA), Pamplona, Spain., de Andrea CE; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdISNA), Pamplona, Spain., Alonso MM; Navarra Institute for Health Research (IdISNA), Pamplona, Spain.; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Program of Solid Tumors, Center for the Applied Medical Research (CIMA), Pamplona, Spain., Boutros P; Department of Human Genetics, University of California Los Angeles, Los Angeles, CA, USA., Robbins J; DNATrix Inc., Carlsbad, CA, USA., Mason WP; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Sonabend AM; Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.; Northwestern Medicine Malnati Brain Tumor Institute of the Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Stupp R; Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.; Northwestern Medicine Malnati Brain Tumor Institute of the Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.; Department of Medicine, Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.; Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Fueyo J; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gomez-Manzano C; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lang FF; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zadeh G; Division of Neurosurgery, University of Toronto, Toronto, Ontario, Canada. gelareh.zadeh@uhn.ca.; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada. gelareh.zadeh@uhn.ca.; Department of Surgery, University of Toronto, Toronto, Ontario, Canada. gelareh.zadeh@uhn.ca. |
| Source: | Nature medicine [Nat Med] 2025 Sep; Vol. 31 (9), pp. 3204. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40691367 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Nassiri+F%22">Nassiri F</searchLink>; Division of Neurosurgery, University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Patil+V%22">Patil V</searchLink>; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Yefet+LS%22">Yefet LS</searchLink>; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Singh+O%22">Singh O</searchLink>; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Liu+J%22">Liu J</searchLink>; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Dang+RMA%22">Dang RMA</searchLink>; Department of Human Genetics, University of California Los Angeles, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Yamaguchi+TN%22">Yamaguchi TN</searchLink>; Department of Human Genetics, University of California Los Angeles, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Daras+M%22">Daras M</searchLink>; Division of Neuro-oncology, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Cloughesy+TF%22">Cloughesy TF</searchLink>; UCLA Neuro-Oncology Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Colman+H%22">Colman H</searchLink>; Huntsman Cancer Institute and Department of Neurosurgery, University of Utah, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Kumthekar+PU%22">Kumthekar PU</searchLink>; Department of Neurology, Division of Neuro-Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Chen+CC%22">Chen CC</searchLink>; Department of Neurosurgery, University of Minnesota, Minneapolis, MI, USA.<br /><searchLink fieldCode="AU" term="%22Aiken+R%22">Aiken R</searchLink>; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Groves+MD%22">Groves MD</searchLink>; Department of Neurology, Texas Oncology, Austin, TX, USA.<br /><searchLink fieldCode="AU" term="%22Ong+SS%22">Ong SS</searchLink>; Division of Neuro-Oncology, Department of Neurology, the Ohio State University Wexner Medical Center, Columbus, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Ramakrishna+R%22">Ramakrishna R</searchLink>; Department of Neurological Surgery, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Vogelbaum+MA%22">Vogelbaum MA</searchLink>; Department of Neuro-Oncology, Neuro-Oncology Program, Moffitt Cancer Center, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Khagi+S%22">Khagi S</searchLink>; Division of Medical Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Kaley+T%22">Kaley T</searchLink>; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Melear+JM%22">Melear JM</searchLink>; Department of Internal Medicine, Baylor University Medical Center, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Peereboom+DM%22">Peereboom DM</searchLink>; The Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Rodriguez+A%22">Rodriguez A</searchLink>; Department of Neurosurgery, University of Arkansas for Medical Sciences, Little Rock, AK, USA.<br /><searchLink fieldCode="AU" term="%22Yankelevich+M%22">Yankelevich M</searchLink>; Department of Pediatrics, University of Michigan, Ann Arbor Beaumont Children's Hospital, Royal Oak, MI, USA.<br /><searchLink fieldCode="AU" term="%22Nair+SG%22">Nair SG</searchLink>; Lehigh Valley Topper Cancer Institute, Allentown, PA, USA.<br /><searchLink fieldCode="AU" term="%22Puduvalli+VK%22">Puduvalli VK</searchLink>; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Aldape+K%22">Aldape K</searchLink>; Laboratory of Pathology, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Gao+A%22">Gao A</searchLink>; Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22López-Janeiro+Á%22">López-Janeiro Á</searchLink>; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdISNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22de+Andrea+CE%22">de Andrea CE</searchLink>; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdISNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Alonso+MM%22">Alonso MM</searchLink>; Navarra Institute for Health Research (IdISNA), Pamplona, Spain.; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.; Program of Solid Tumors, Center for the Applied Medical Research (CIMA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Boutros+P%22">Boutros P</searchLink>; Department of Human Genetics, University of California Los Angeles, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Robbins+J%22">Robbins J</searchLink>; DNATrix Inc., Carlsbad, CA, USA.<br /><searchLink fieldCode="AU" term="%22Mason+WP%22">Mason WP</searchLink>; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Sonabend+AM%22">Sonabend AM</searchLink>; Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.; Northwestern Medicine Malnati Brain Tumor Institute of the Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Stupp+R%22">Stupp R</searchLink>; Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.; Northwestern Medicine Malnati Brain Tumor Institute of the Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.; Department of Medicine, Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.; Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Fueyo+J%22">Fueyo J</searchLink>; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Gomez-Manzano+C%22">Gomez-Manzano C</searchLink>; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Lang+FF%22">Lang FF</searchLink>; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Zadeh+G%22">Zadeh G</searchLink>; Division of Neurosurgery, University of Toronto, Toronto, Ontario, Canada. gelareh.zadeh@uhn.ca.; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada. gelareh.zadeh@uhn.ca.; Department of Surgery, University of Toronto, Toronto, Ontario, Canada. gelareh.zadeh@uhn.ca. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2025 Sep; Vol. 31 (9), pp. 3204. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40691367 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41591-025-03895-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3204 Titles: – TitleFull: Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nassiri F – PersonEntity: Name: NameFull: Patil V – PersonEntity: Name: NameFull: Yefet LS – PersonEntity: Name: NameFull: Singh O – PersonEntity: Name: NameFull: Liu J – PersonEntity: Name: NameFull: Dang RMA – PersonEntity: Name: NameFull: Yamaguchi TN – PersonEntity: Name: NameFull: Daras M – PersonEntity: Name: NameFull: Cloughesy TF – PersonEntity: Name: NameFull: Colman H – PersonEntity: Name: NameFull: Kumthekar PU – PersonEntity: Name: NameFull: Chen CC – PersonEntity: Name: NameFull: Aiken R – PersonEntity: Name: NameFull: Groves MD – PersonEntity: Name: NameFull: Ong SS – PersonEntity: Name: NameFull: Ramakrishna R – PersonEntity: Name: NameFull: Vogelbaum MA – PersonEntity: Name: NameFull: Khagi S – PersonEntity: Name: NameFull: Kaley T – PersonEntity: Name: NameFull: Melear JM – PersonEntity: Name: NameFull: Peereboom DM – PersonEntity: Name: NameFull: Rodriguez A – PersonEntity: Name: NameFull: Yankelevich M – PersonEntity: Name: NameFull: Nair SG – PersonEntity: Name: NameFull: Puduvalli VK – PersonEntity: Name: NameFull: Aldape K – PersonEntity: Name: NameFull: Gao A – PersonEntity: Name: NameFull: López-Janeiro Á – PersonEntity: Name: NameFull: de Andrea CE – PersonEntity: Name: NameFull: Alonso MM – PersonEntity: Name: NameFull: Boutros P – PersonEntity: Name: NameFull: Robbins J – PersonEntity: Name: NameFull: Mason WP – PersonEntity: Name: NameFull: Sonabend AM – PersonEntity: Name: NameFull: Stupp R – PersonEntity: Name: NameFull: Fueyo J – PersonEntity: Name: NameFull: Gomez-Manzano C – PersonEntity: Name: NameFull: Lang FF – PersonEntity: Name: NameFull: Zadeh G IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2025 Sep Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1546-170X Numbering: – Type: volume Value: 31 – Type: issue Value: 9 Titles: – TitleFull: Nature medicine Type: main |
| ResultId | 1 |